SCHEMBL7368715

SCHEMBL7368715

O=C(O)NCCC(=O)C1CCCCC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.42
EPHX1 P07099 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.40
HSD17B10 Q99714 1/20 0.40
NAAA Q02083 1/20 0.40
CES2 O00748 1/20 0.39
CES1 P23141 1/20 0.39
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
EPHX2 P34913 3/20 0.39
ITGB3 P05106 2/20 0.37
ITGA2B P08514 2/20 0.37
F2R P25116 2/20 0.37
NPC1 O15118 1/20 0.37
PKM P14618 1/20 0.37
RAB9A P51151 1/20 0.37
ALDH1A1 P00352 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
HSD11B1 P28845 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL784986 0.79 CYP2D6 (0.44) CYP2D6EPHX1SMN1; SMN2HSD17B10NAAA
SCHEMBL13939832 0.77 SMN1; SMN2 (0.50) EPHX1SMN1; SMN2HSD17B10ALDH1A1MEN1
SCHEMBL23354173 0.77 CYP2D6 (0.41) CYP2D6EPHX1SMN1; SMN2HSD17B10NAAA
SCHEMBL3763770 0.75 EPHX1 (0.60) EPHX1SMN1; SMN2HSD17B10EPHX2ITGB3
SCHEMBL6062059 0.75 EPHX1 (0.61) CYP2D6EPHX1EPHX2NPC1RAB9A
SCHEMBL3990546 0.74 HPGD (0.53) EPHX1SMN1; SMN2HSD17B10CES2CES1
SCHEMBL13332473 0.74 HPGD (0.53) EPHX1SMN1; SMN2HSD17B10CES2CES1
SCHEMBL2400052 0.74 ALDH1A1 (0.50) EPHX1CES2CES1HDAC8HDAC6
SCHEMBL8536055 0.74 ALDH1A1 (0.50) EPHX1CES2CES1HDAC8HDAC6
SCHEMBL1088091 0.73 CES2 (0.50) EPHX1SMN1; SMN2HSD17B10NAAACES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0231919-A2 N-Heterocyclic alcohol renin inhibitors E.R. Squibb & Sons, Inc. (US) 1987-08-12 EP disclosed